Efficacy of anti-severe acute respiratory syndrome coronavirus 2 mRNA vaccines in adults with severe acquired aplastic anemia with or without allogeneic hematopoietic stem cell transplantation

EJHaem. 2022 Sep 28;3(4):1442-1444. doi: 10.1002/jha2.570. eCollection 2022 Nov.
No abstract available

Keywords: BNT162b2; COVID‐19; SARS‐CoV‐2 mRNA; allogeneic; aplastic anemia; third dose; vaccine.